Ivermectin — a drug once touted as a Covid treatment by conservatives — doesn’t improve recovery much, clinical trial finds
“These findings do not support the use of ivermectin in patients with mild to moderate COVID-19,” the scientists concluded.
Leslie Jordan, ‘Will & Grace’ actor, dies at 67
His witty Instagram posts made him a social media sensation during the pandemic.
Goldman Sachs sees path to a soft landing for the economy getting clearer
There may be a path to a soft landing after all. At least that’s what economists think at Goldman Sachs.
Apple raises prices on its TV and Music streaming services
In a statement, Apple said the price increase for Apple Music was because of increased music licensing costs.
Apple reports earnings Thursday and all eyes are on iPhone 14 sales
Apple reports its fourth-quarter earnings on Thursday. The highlight will be an insight into how the iPhone 14 series is selling.
63% of Americans are living paycheck to paycheck — including nearly half of six-figure earners
With persistent inflation eating away at wage gains, more Americans are struggling financially. The share living paycheck to paycheck is near a historic high.
Meta shareholder writes critical open letter saying company needs to slash headcount and stop spending so much money on ‘metaverse’
The Meta investor says the company can get its “mojo back” by reducing headcount and limiting the company’s investments in “metaverse” technology.
The new iPad Pro is Apple’s best iPad, but it’s overkill for most people
The new 2022 iPad Pro has an M2 chip, making it Apple’s most powerful iPad yet. If you have last year’s Pro, it might be hard to justify upgrading.
The new iPad got a major makeover, and it’s worth the extra $120
Apple’s new entry-level iPad is $120 more expensive than last year’s model, but it’s worth the cost if you have an iPad that’s two or more years old.
